Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 1992

Conditions
AIDS Dementia ComplexHIV Infections
Interventions
DRUG

Zidovudine

DRUG

Didanosine

Trial Locations (13)

10029

Mount Sinai Med Ctr, New York

14642

Univ of Rochester Medical Center, Rochester

21287

Johns Hopkins Hosp, Baltimore

29169

Julio Arroyo, West Columbia

55455

Univ of Minnesota, Minneapolis

70112

Charity Hosp / Tulane Univ Med School, New Orleans

Louisiana State Univ Med Ctr / Tulane Med School, New Orleans

Tulane Univ School of Medicine, New Orleans

275997215

Univ of North Carolina, Chapel Hill

462025250

Indiana Univ Hosp, Indianapolis

941102859

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco

San Francisco Gen Hosp, San Francisco

981224304

Univ of Washington, Seattle

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Glaxo Wellcome

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH